Robinson, E. v. Madeline C. Weiser, M.D., P.C.

CourtSuperior Court of Pennsylvania
DecidedJune 27, 2019
Docket1242 EDA 2018
StatusUnpublished

This text of Robinson, E. v. Madeline C. Weiser, M.D., P.C. (Robinson, E. v. Madeline C. Weiser, M.D., P.C.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Robinson, E. v. Madeline C. Weiser, M.D., P.C., (Pa. Ct. App. 2019).

Opinion

J-A25007-18

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37

ELIZABETH ROBINSON, M.D. : IN THE SUPERIOR COURT OF : PENNSYLVANIA Appellant : : : v. : : : MADELINE C. WEISER, M.D., P.C. : No. 1242 EDA 2018

Appeal from the Judgment Entered April 16, 2018 In the Court of Common Pleas of Montgomery County Civil Division at No(s): No. 2011-27436

ELIZABETH ROBINSON, M.D. : IN THE SUPERIOR COURT OF : PENNSYLVANIA : v. : : : MADELINE C. WEISER, M.D., P.C. : : Appellant : No. 1284 EDA 2018

Appeal from the Judgment Entered April 16, 2018 In the Court of Common Pleas of Montgomery County Civil Division at No(s): 11-27436

BEFORE: PANELLA, J., DUBOW, J., and KUNSELMAN, J.

CONCURRING/DISSENTING MEMORANDUM BY KUNSELMAN, J.:FILED JUNE

27, 2019

While I agree with the Majority’s decision regarding the Employee’s

issues on appeal, I disagree with the decision regarding the Employer’s first

and second issues. I believe that the trial court erred as a matter of law in

concluding that the contractual term “net collected receipts” is ambiguous. I

also believe the unambiguous use of that term allowed the Employer to deduct J-A25007-18

its cost of the vaccines from the total collected receipts before calculating the

Employee’s compensation. Thus, I dissent from the majority on those two

issues and concur with the rest of the decision.

Whether a contract contains ambiguous terms is a question of law.

Walton v. Philadelphia Nat. Bank., 545 A.2d 1383, 1388 (Pa. Super.

1988). “Because contract interpretation is a question of law, this Court is not

bound by the trial court's interpretation.” Mazurek v. Russell, 96 A.3d 372,

378 (Pa. Super. 2014) (citation omitted). “Our standard of review over

questions of law is de novo and to the extent necessary, the scope of our

review is plenary as [the appellate] court may review the entire record in

making its decision.” Id. (citation omitted)

“A contract is ambiguous if it is reasonably susceptible of different

constructions and capable of being understood in more than one sense.” Ins.

Adjustment Bureau. Inc. v. Allstate Ins. Co, 905 A.2d 462, 469 (Pa.

2006). The fact that the parties do not agree upon a proper interpretation

does not necessarily render a contract ambiguous. Krizovensky v.

Krizovensky, 624 A.2d 638, 642 (Pa. Super. 1993).

Here, the trial court found the term “net collected receipts” ambiguous,

and allowed the parties to testify about their individual understanding of this

term.1 I disagree that the term is ambiguous. The term “net” in business

____________________________________________

1Plaintiff testified that there was no written or oral agreement to include the cost of vaccines as part of her "net collected receipts" and that she never

-2- J-A25007-18

commonly refers to the amount remaining after expenses have been

deducted. See Meriam-Webster Online Dictionary, https://www.merriam-

webster.com/dictionary/net, (last visited 5/16/19) (defining “net” as “free

from all charges or deductions: such as: remaining after the deduction of all

charges, outlay, or loss”). Otherwise, the parties would have used the term

“gross” which refers to the total amount before accounting for any expenses

or deductions. See id., https://www.merriam-webster.com/dictionary/gross,

(last visited 5/16/19) (defining “gross” as “consisting of an overall total

exclusive of deductions”).

Our court has previously found the term net to be unambiguous. See

Temple University v. Allegheny Health Educ. and Research

Foundation, 690 A.2d 712, 716 (Pa. Super. 1997) (finding “the term net

payment does not even achieve the need for translation, let alone attain such

uncertainty as to invoke the designation ambiguity and thereby permit . . .

the presentation of extrinsic evidence.”); Faust v. Walker, 945 A.2d 212,

214-15 (Pa. Super. 2008) (finding “net proceeds” is not an ambiguous term).

would have agreed to include deduction of vaccine costs as part of her agreement with defendant. N.T., 9/6/17/ at 102-03. The court found Dr. Robinson's testimony that there was no agreement to include the cost of vaccines as part of her "net collected receipts" to be credible. Trial Court Opinion, 10/20/2017, at 4. The fact that the trial court found this testimony to be credible is of no consequence; the court should never have considered parole evidence of the parties’ understanding of the term “net collected receipts” since the term was not ambiguous. See Steuart v. McChesney, 444 A.2d 659, 661 (Pa. 1982). (explaining “[w]hen the words of a contract are clear and unambiguous, the intent is to be discovered only from the express language of the agreement”).

-3- J-A25007-18

But see contra Lohmann v. Piczon, 487 A.2d 1386 (Pa. Super. 1985)

(remanding to allow parole evidence to determine the meaning of “net income

after taxes” in parties’ support agreement).

Because the term is unambiguous, the trial court erred when it

considered the Employee’s unilateral understanding of this term. The trial

court further erred when it completely disregarded the term “net” in

calculating the Employee’s income under the parties’ agreement. The trial

court calculated the Employee’s salary by taking the total receipts collected

and multiplying by 49%. By doing so, the court effectively changed the

language in the contract from “net” collected receipts to “gross” collected

receipts. That clearly was not the parties’ intention, since they specifically

used the word “net” in their contract.

Moreover, to hold as the Majority and the trial court have done, requires

the Employer to pay twice for the cost of the vaccines. First, the Employer

has to pay the vendors who sold it the vaccines, and second, the Employer

has to pay 49% of that cost again, when it compensates the Employee. That

does not make good business sense, and it is not what the express language

of the parties’ contract provides.

The fact that the parties did not define this term in their agreement did

not render the term ambiguous. The common, unambiguous, use of that word

meant the parties agreed that they would deduct expenses from the amount

collected before calculating the Employee’s percentage of compensation.

-4- J-A25007-18

As the Employer testified, she did not seek to include other categories

of expenses in the “net” calculation, because they were not easily allocable

among the Employer’s doctors. However, the cost of vaccines was a readily

ascertainable expense that could be individually attributed to each employee.

As such, it was reasonable, foreseeable, and agreed upon by the parties in the

contract that this expense would be deducted as part of “net” receipts, before

calculating the Employee’s salary.2

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Walton v. Philadelphia National Bank
545 A.2d 1383 (Supreme Court of Pennsylvania, 1988)
Krizovensky v. Krizovensky
624 A.2d 638 (Superior Court of Pennsylvania, 1993)
Insurance Adjustment Bureau, Inc. v. Allstate Insurance
905 A.2d 462 (Supreme Court of Pennsylvania, 2006)
Lohmann v. Piczon
487 A.2d 1386 (Supreme Court of Pennsylvania, 1985)
Steuart v. McChesney
444 A.2d 659 (Supreme Court of Pennsylvania, 1982)
Faust v. Walker
945 A.2d 212 (Superior Court of Pennsylvania, 2008)
Mazurek v. Russell
96 A.3d 372 (Superior Court of Pennsylvania, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Robinson, E. v. Madeline C. Weiser, M.D., P.C., Counsel Stack Legal Research, https://law.counselstack.com/opinion/robinson-e-v-madeline-c-weiser-md-pc-pasuperct-2019.